Literature DB >> 24411278

Is treatment of the primary tumor in metastatic prostate cancer justified?

Brian F Chapin1, Sean E McGuire2, Ana Aparicio2.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 24411278     DOI： 10.1016/j.eururo.2013.12.011

Source DB:  PubMed          Journal:  Eur Urol        ISSN： 0302-2838            Impact factor:   20.096


× No keyword cloud information.
  2 in total

Review 1.  Role of radical prostatectomy in clinically non-organ-confined prostate cancer.

Authors:  Christian Gratzke; Jutta Engel; Christian G Stief
Journal:  Curr Urol Rep       Date:  2014-11       Impact factor: 3.092

2.  Surgical cytoreduction of the primary tumor reduces metastatic progression in a mouse model of prostate cancer.

Authors:  Federico F Cifuentes; Rodrigo H Valenzuela; Héctor R Contreras; Enrique A Castellón
Journal:  Oncol Rep       Date:  2015-12       Impact factor: 3.906
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.